Laura Barnabei
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A large deletion in a non-coding regulatory region leads to NFKB1 haploinsufficiency in two adult siblings.
Journal: Clinical immunology (Orlando, Fla.)
Published: October 10, 2023
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms.
Journal: Molecular cancer therapeutics
Published: February 02, 2023
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms.
Journal: bioRxiv : the preprint server for biology
Published: January 30, 2023
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors.
Journal: Journal of clinical medicine
Published: December 01, 2022
A DNA biosensors-based microfluidic platform for attomolar real-time detection of unamplified SARS-CoV-2 virus.
Journal: Biosensors & bioelectronics: X
Published: October 21, 2022
When speed matters: a discussion on the benefits of a grace period in patent law to accelerate pharmaceutical innovation in times of pandemic.
Journal: Journal of law and the biosciences
Published: October 28, 2021
Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak.
Journal: The British journal of dermatology
Published: August 21, 2021
NF-κB: At the Borders of Autoimmunity and Inflammation.
Journal: Frontiers in immunology
Published: May 28, 2021
A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis.
Journal: Med (New York, N.Y.)
Published: April 02, 2021
ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 23, 2021
Last Updated: 09/26/2026